<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.nutraingredients.com/Article/2026/10/02/nutracast-beyond-the-coa-testing-blind-spots-put-brands-at-risk/</loc>
    <lastmod>2026-10-02T14:41:35.067Z</lastmod>
    <changefreq>always</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>NutraIngredients.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02T14:41:35.067Z</news:publication_date>
      <news:title><![CDATA[NutraCast: Beyond the COA – Testing blind spots put brands at risk]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://www.nutraingredients.com/resizer/v2/M3XBPOU6F5ACRHVGU4MAWIK7DY.jpg?auth=d9a29dd81d52d7f8d6e4ec2fb4516e0e9469ac904bd2f6c5cced62e95a3da1e0&amp;smart=true&amp;width=824&amp;height=465</image:loc>
      <image:caption><![CDATA[The NutraCast explores the trends, science and issues shaping the dietary supplement industry.]]></image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.nutraingredients.com/Article/2026/10/02/market-moves-supplement-industry-deals-of-q3-2026/</loc>
    <lastmod>2026-10-02T14:41:05.476Z</lastmod>
    <changefreq>always</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>NutraIngredients.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02T14:41:05.476Z</news:publication_date>
      <news:title><![CDATA[Market Moves: Supplement industry deals of Q3 2026]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://www.nutraingredients.com/resizer/v2/5YEGOPHMGNCFXDCT5KN5INIS2I.jpg?auth=ea40088b78344e26a9f4adb2118d26292dcdc39192545d646f75e4ad6f86d45e&amp;smart=true&amp;width=824&amp;height=465</image:loc>
      <image:caption><![CDATA[Scale still matters, but defensible science, traceable supply chains, specialized production and access to high-value channels are increasingly shaping where capital and strategic interest converge.]]></image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.nutraingredients.com/Article/2026/10/02/npa-opinion-on-drug-preclusion-and-the-dietary-supplement-innovation-act/</loc>
    <lastmod>2026-10-02T14:39:17.074Z</lastmod>
    <changefreq>always</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>NutraIngredients.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02T14:39:17.074Z</news:publication_date>
      <news:title><![CDATA[Drug preclusion: Consider the source]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://www.nutraingredients.com/resizer/v2/H7KHP4MMDZG45JHDTNR6NQ5JOU.jpg?auth=7e4b68120f5a2e90820cfeddc5d0b3916d2a8dda9d66dd3480a8f4f09dc46fd0&amp;smart=true&amp;width=824&amp;height=465</image:loc>
      <image:caption><![CDATA[On Sept. 10, Congresswoman Diana Harshbarger (R-TN) introduced the Dietary Supplement Innovation Act, legislation to modernize the Food and Drug Administration’s (FDA) drug preclusion provision.]]></image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.nutraingredients.com/Article/2026/10/02/botanical-safety-is-article-8-fit-for-purpose/</loc>
    <lastmod>2026-10-02T12:02:07.032Z</lastmod>
    <changefreq>always</changefreq>
    <priority>0.5</priority>
    <news:news>
      <news:publication>
        <news:name>NutraIngredients.com</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02T12:02:07.032Z</news:publication_date>
      <news:title><![CDATA[Botanical safety: Is Article 8 fit for purpose? ]]></news:title>
    </news:news>
    <image:image>
      <image:loc>https://www.nutraingredients.com/resizer/v2/JUZTWUMI4ZCEVPC4ONHKLBX5PE.jpg?auth=08b51bae851ed7292be1c3e8da611866336293f8c8f274a1ce3fc822f0a1a190&amp;smart=true&amp;width=7000&amp;height=4000</image:loc>
      <image:caption><![CDATA[While regulatory concern about certain botanicals and are legitimate, the procedure used to restrict or prohibit these substances has its faults, according to Dr. Thomas Brendler.]]></image:caption>
    </image:image>
  </url>
</urlset>